Commodore Capital’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Hold |
290,000
| – | – | 0.89% | 26 |
|
|
2025
Q1 | $10.8M | Hold |
290,000
| – | – | 0.8% | 25 |
|
|
2024
Q4 | $13.1M | Hold |
290,000
| – | – | 0.96% | 23 |
|
|
2024
Q3 | $17M | Hold |
290,000
| – | – | 1.06% | 28 |
|
|
2024
Q2 | $11.4M | Hold |
290,000
| – | – | 0.78% | 27 |
|
|
2024
Q1 | $19.3M | Buy |
290,000
+40,000
| +16% | +$2.66M | 1.29% | 26 |
|
|
2023
Q4 | $6.99M | Hold |
250,000
| – | – | 0.61% | 30 |
|
|
2023
Q3 | $5.33M | Buy |
+250,000
| New | +$5.33M | 0.62% | 27 |
|